PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma. Stewart J, Krastev DB, Brough R, Zatreanu D, et al. Oncogene 2025 Feb 12. doi: 10.1038/s41388-024-03265.

Read + Share

Amedeo Smart

Independent Medical Education

Stewart J, Krastev DB, Brough R, Zatreanu D, et al. PPP2R1A mutations cause ATR inhibitor sensitivity in ovarian clear cell carcinoma. Oncogene 2025 Feb 12. doi: 10.1038/s41388-024-03265.
PMID: 39939726